Cell Cycle Deregulation in Cancers
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (15 October 2013) | Viewed by 80355
Special Issue Editor
Interests: cell cycle; cyclins; cyclin/CDKs; post-transcriptional control of gene expression; RNA binding proteins; microRNAs; cell cycle deregulation in cancer; developmental basis of cancer; microenvironmental control of the cell cycle
Special Issue Information
Dear Colleagues,
Loss of normal cell cycle control is a hallmark of cancer, resulting in targeting of cell cycle regulators for cancer therapy. In general, strategies used to exploit the deregulated cancer cell cycle by directly targeting cell cycle regulators do not provide cancer specificity. This issue of Cancers invites contributions of original research reports, clinical studies, and review articles that focus on cancer specific modifications that would allow indirect targeting of cell cycle deregulation. Potential topics include modifications of the microenvironment, inflammatory signaling, stress response, and post-transcriptional events that result in cell cycle deregulation.
Dr. Rebecca S. Hartley
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell cycle regulators
- cell cycle deregulation
- cancer cell cycle
- cancer specific modifications
- cancer vulnerabilities
- cancer therapy
- tumor microenvironment
- inflammatory signaling
- stress response
- post-transcription